Research Library

Read the Baker Institute Blog for the latest updates on the spread of Covid-19 and the best defenses against it.

An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.

President López Obrador was skeptical of the coronavirus threat and ignored the recommendations of his own health experts. He downplayed the crisis and relied on his intuition instead of science, with disastrous results. He will be even more distracted in the coming months as he campaigns for re-election.

The death of George Floyd has accelerated calls for police reform. Although decriminalizing drugs and the people who use them will not end police violence, it is part of the structural change needed to fix the problem, writes fellow Katharine Neill Harris.

The collective trauma of the Covid-19 pandemic may provide a clearer understanding of why people use drugs — to help us see it not as a moral failing or a brain malfunction, but as a fundamentally human response to negative life events. Read more at the Baker Institute Blog.

"This pandemic and looming economic crisis will affect all of us ... The sooner we relearn how to set aside our differences and unite during this difficult moment, the stronger we will emerge from it," writes former Secretary James A. Baker, III.

Even before the pandemic, Mexico’s health care system was in crisis, with shortages of medical supplies, drugs, and personnel. A president that is downplaying the outbreak, brandishing amulets to “protect” him from the virus, isn’t helping matters. Baker Institute blog: https://bit.ly/2w6KJHV

Baker Institute health policy experts provide links to some of the sources they found helpful in understanding developments in the coronavirus outbreak.

Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.